FI932572A - Farmaceutiska preparat innehaollande funktionaliserade vinylazoler, anvaendning av dessa vinylazoler foer framstaellning av laekemedel, vinylazoler samt foerfaranden foer deras framstaellning - Google Patents

Farmaceutiska preparat innehaollande funktionaliserade vinylazoler, anvaendning av dessa vinylazoler foer framstaellning av laekemedel, vinylazoler samt foerfaranden foer deras framstaellning Download PDF

Info

Publication number
FI932572A
FI932572A FI932572A FI932572A FI932572A FI 932572 A FI932572 A FI 932572A FI 932572 A FI932572 A FI 932572A FI 932572 A FI932572 A FI 932572A FI 932572 A FI932572 A FI 932572A
Authority
FI
Finland
Prior art keywords
insulators
vinyl
functional
alternatives
manufacture
Prior art date
Application number
FI932572A
Other languages
English (en)
Other versions
FI932572A0 (fi
Inventor
Peter Strehlke
Rolf Bohlmann
Martin Schneider
Yukishige Nishino
Hans-Peter Muhn-Seipoldy
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI932572A publication Critical patent/FI932572A/fi
Publication of FI932572A0 publication Critical patent/FI932572A0/fi
Priority to FI970167A priority Critical patent/FI970167A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI932572A 1990-12-07 1993-06-04 Farmaceutiska preparat innehaollande funktionaliserade vinylazoler, anvaendning av dessa vinylazoler foer framstaellning av laekemedel, vinylazoler samt foerfaranden foer deras framstaellning FI932572A0 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI970167A FI970167A (fi) 1990-12-07 1997-01-15 Fuktionalisoituja vinyyliatsoleja sisältäviä ehkäisyainevalmisteita, itse vinyyliatsoleja sekä menetelmiä niiden valmistamiseksi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4039559A DE4039559A1 (de) 1990-12-07 1990-12-07 Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln

Publications (2)

Publication Number Publication Date
FI932572A true FI932572A (fi) 1993-06-04
FI932572A0 FI932572A0 (fi) 1993-06-04

Family

ID=6420083

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932572A FI932572A0 (fi) 1990-12-07 1993-06-04 Farmaceutiska preparat innehaollande funktionaliserade vinylazoler, anvaendning av dessa vinylazoler foer framstaellning av laekemedel, vinylazoler samt foerfaranden foer deras framstaellning

Country Status (17)

Country Link
US (1) US5344834A (fi)
EP (1) EP0550697A1 (fi)
JP (1) JPH06503818A (fi)
KR (1) KR930703263A (fi)
CN (1) CN1064863A (fi)
AU (1) AU660296B2 (fi)
CA (1) CA2097824C (fi)
CS (1) CS369691A3 (fi)
DE (1) DE4039559A1 (fi)
FI (1) FI932572A0 (fi)
HU (1) HUT64036A (fi)
IE (1) IE914259A1 (fi)
IL (1) IL100274A (fi)
NO (1) NO304428B1 (fi)
PT (1) PT99714B (fi)
WO (1) WO1992010482A1 (fi)
ZA (1) ZA919662B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
EP0943333A1 (de) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
US20020086856A1 (en) 1998-03-18 2002-07-04 Alfred Schmidt Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
CN100358866C (zh) * 2004-04-08 2008-01-02 上海交通大学 含对强碱不稳定取代基的n-乙烯基取代吡咯的制备方法
JP6470984B2 (ja) * 2015-01-27 2019-02-13 学校法人東日本学園 アロマターゼ阻害剤及びこれを含む医薬
CN105732977B (zh) * 2016-01-30 2018-03-02 宝鸡文理学院 一种可溶性聚苯并二噻唑‑酰胺荧光聚合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580535A (en) * 1976-08-27 1980-12-03 Ici Ltd Substituted ketones and their use as herbicides
EP0003884A3 (en) * 1978-02-23 1979-09-19 Imperial Chemical Industries Plc Alpha-beta unsaturated ketone derivatives useful as herbicides
DE2826760A1 (de) * 1978-06-19 1980-01-03 Hoechst Ag Derivate des 1,2,4-triazols
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd N−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
GB8716650D0 (en) * 1987-07-15 1987-08-19 Ici Plc Use of olefinic compounds

Also Published As

Publication number Publication date
IL100274A0 (en) 1992-09-06
AU660296B2 (en) 1995-06-22
HUT64036A (en) 1993-11-29
ZA919662B (en) 1992-09-30
AU9045491A (en) 1992-07-08
HU9301657D0 (en) 1993-09-28
JPH06503818A (ja) 1994-04-28
NO304428B1 (no) 1998-12-14
NO932044L (no) 1993-06-04
PT99714B (pt) 1999-05-31
NO932044D0 (no) 1993-06-04
IL100274A (en) 1996-08-04
CN1064863A (zh) 1992-09-30
DE4039559A1 (de) 1992-06-11
CS369691A3 (en) 1992-06-17
FI932572A0 (fi) 1993-06-04
US5344834A (en) 1994-09-06
WO1992010482A1 (de) 1992-06-25
KR930703263A (ko) 1993-11-29
PT99714A (pt) 1992-10-30
CA2097824A1 (en) 1992-06-08
IE914259A1 (en) 1992-06-17
CA2097824C (en) 2003-04-08
EP0550697A1 (de) 1993-07-14

Similar Documents

Publication Publication Date Title
NO175287C (no) Fremgangsmåte for fremstilling av et intravenöst, farmasöytisk preparat
FI822770L (fi) Bensazepin-2-oner, foerfarande foer deras framstaellning, farmaceutiska preparat innehaollande dess foereningar samt deras terapeutiska anvaendning
FI903382A0 (fi) Topiskt anbringbara farmaceutiska preparat.
FI873630A (fi) Stabilt farmaceutiskt preparat.
NO911139L (no) Fremgangsmaate for fremstilling av lavere olefiner.
NO890494D0 (no) Begroingshindrende preparat.
IT8247937A0 (it) Polipeptedi, loro preparazione eloro impiego come medicamenti
FI794006A (fi) Farmaceutiskt preparat omfattande en hjaertglykosid i kombination med en polymer
FI874163A0 (fi) Katekolderivat samt preparat innehaollande desamma foer haemmande och botande av regressiva sjukdomar i det centrala nervsystemet.
NO884052L (no) Fremgangsmaate for fremstilling av terapeutisk preparat.
FI822187L (fi) Farmaceutiska preparat
FI820877L (fi) Nya tiazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning
FI932572A0 (fi) Farmaceutiska preparat innehaollande funktionaliserade vinylazoler, anvaendning av dessa vinylazoler foer framstaellning av laekemedel, vinylazoler samt foerfaranden foer deras framstaellning
FI874382A0 (fi) Farmaceutiska preparat.
FI883638A0 (fi) Foerfarande foer framstaellning av saorlaekningsfraemjande farmaceutiska preparat.
FI860014A0 (fi) Preparat med foerdroejd verkan, foerfarande foer deras framstaellning samt motsvarande preparat foer human- eller veterinaermedicinsk anvaendning.
FI883468A0 (fi) Foerfarande foer framstaellning av farmaceutiska preparat.
IT1122914B (it) 2-amminoetil-1-fenil-indoline,loro preparazione e loro applicazione come medicamenti
IT8848638A0 (it) Peptidi contenenti silicio, loro preparazione e loro impiego come medicamenti
FI834138A0 (fi) Heterocyklylfoereningar, dessa foereningar innehaollande farmaceutiska preparat samt deras anvaendning
FI913845A0 (fi) Farmaceutiskt preparat foer behandling av tonsillitis.
FI932396A0 (fi) Foerfarande foer framstaellning av en dubbelskyddad 2,3-hydroximetylcyklobutanol
FI883747A (fi) Topiskt anvaendbara farmaceutiska preparat.
FI823304L (fi) Amino-oxazolylfoereningar, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat samt anvaendning av de sistnaemnda
FI810874L (fi) Farmaceutiska preparat